Promimic

Promimic's nanotechnology HAnano Surface creates a unique bioactive surface on any implant. HAnano Surface has demonstrated faster and stronger osseointegration capabilities in over 30 in vivo and in vitro studies, with more than 250,000 clinical applications to date. HAnano Surface is a 20-nanometer thin implant surface modification composed of crystalline hydroxyapatite (HA) particles, identical in shape, composition, and structure to HA found in human bone. Promimic primarily operates in the United States, Europe, and South America, with current products targeting dental, spinal, total joint, extremity, and sports medicine implant markets. Product development and commercialization partners: Partnering with medical device companies at all stages of product development and commercialization, including initial feasibility and optimization, testing and regulatory submission, production setup and implementation, as well as launch and marketing support. The business model is flexible, based on customer needs and capabilities. Clear regulatory pathway: Licensees can access Promimic’s extensive HAnano Surface preclinical and clinical database. Established manufacturing process: Production can be carried out through Promimic’s contract manufacturing partner Danco Anodizing or easily established within the customer’s internal manufacturing facility. Licensees can access Promimic’s extensive HAnano Surface preclinical and clinical database. Established manufacturing process: Production can be carried out through Promimic’s contract manufacturing partner Danco Anodizing or easily established within the customer’s internal manufacturing facility. Licensees can access Promimic’s extensive HAnano Surface preclinical and clinical database. Established manufacturing process: Production can be carried out through Promimic’s contract manufacturing partner Danco Anodizing or easily established within the customer’s internal manufacturing facility.